Harnessing the innate and adaptive immune system with targeted neoantigen based cancer vaccines

Project description

Industry and academia come together to expedite delivery of personalised immunotherapy

Field of science

• /natural sciences/biological sciences/genetics and heredity/mutation
• /medical and health sciences/basic medicine/immunology
• /medical and health sciences/clinical medicine/cancer

Programme(s)

• H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility

Topic(s)

• MSCA-IF-2018 - Individual Fellowships

Call for proposal

H2020-MSCA-IF-2018
See other projects for this call

Funding Scheme

MSCA-IF-EF-SE - Society and Enterprise panel

Coordinator

PROTEODESIGN SL

Address

Baldiri Reixac 10-12
08028 Barcelona
Spain

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 172 932,48